Skip to main content

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More

Shannon Conneely, MD


Texas Medical Center

Cancer and Hematology
Phone: 832-824-3983
Fax: 832-825-1453


6701 Fannin, Ste. 1510
Houston, TX 77030

Shannon E. Conneely, MD

Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine


School Education Degree Year
Baylor College of Medicine Fellowship Pediatric Hematology-Oncology 2020
Cincinnati Children's Hospital Medical Center Residency Pediatrics 2016
University of Cincinnati College of Medicine Medical School Doctor of Medicine 2013
Ohio State University Bachelors Bachelor of Science, Biomedical Science 2009


Dr. Shannon Conneely completed her pediatric hematology/oncology fellowship training in 2020. Prior to her fellowship training, she worked at Texas Children's Hospital on the inpatient oncology unit as a hospitalist assisting in the medical care of a variety of pediatric oncology patients.

She developed an interest in pediatric cancer care as a high school student volunteering at her local children's hospital in Ohio. She hopes to help many children to live full and happy lives after a cancer diagnosis while minimizing the side effects of cancer therapy.

She is board certified by the American Board of Pediatrics.


Organization Name Role
American Academy of Pediatrics (AAP) Member
American Society of Clinical Oncology (ASCO) Member
American Society of Hematology (ASH) Member
American Society of Pediatric Hematology/Oncology (ASPHO) Member
Children's Oncology Group (COG) Member

Research Statement

Dr. Conneely's research focuses on better understanding the mechanism behind certain types of leukemia, specifically acute myeloid leukemia (AML). She is trying to identify protein interactions that either help or prevent AML cells from dividing and driving disease. The overall goal is to identify potential new pathways that can be targeted for therapies in the future to improve outcomes for patients with AML.

Laboratory of Rachel Rau, MD

Selected Publications

Board Certification

American Board of Pediatrics



* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.